Unfortunately, Internet Explorer is an outdated browser and we do not currently support it. To have the best browsing experience, please upgrade to Google Chrome.
Find out what's going on at One Health Group.
One Health (AQUIS: OHGR), a provider of NHS-funded medical procedures for patients referred for treatment in Orthopaedics, Spine, General Surgery and Gynaecology, is pleased to provide the following trading update for the year to 31 March 2023.
TR1 – Notification of Major Holdings
OHGR Total Voting Rights announcement
One Health Group PLC (“One Health” or the “Company”) announces that Shantanu Shahane, a director and person discharging managerial responsibilities in the Company, purchased 60,000 ordinary shares of 0.5 pence each in the capital of the Company (“Ordinary Shares”) following the exercise of options granted under the One Health Group Share Option Plan (“Share Options”).
One Health (AQSE: OHGR), a provider of NHS-funded medical procedures, announces that it has issued 476,760 new ordinary shares of 0.5 pence each in the Company (the "New Ordinary Shares") pursuant to the exercise of options under the One Health Group Share Option Plan.
OHGR PDMR dealing and TR1 announcement
One Health (AQSE: OHGR), a provider of NHS-funded medical procedures, announces its unaudited interim results for the six months ended 30 September 2022. Subsequent to the period end, on 24 November 2022 the Company was admitted to the Apex segment of the AQSE Growth Market following a Placing of and Subscription for ordinary shares at 150p per share.
One Health Group plc (AQSE: OHGR), a provider of NHS-funded medical procedures, announces its first day of dealings and Admission of its ordinary shares to trading on the Apex segment of the AQSE Growth Market (“Admission”) at 8.00am today under the ticker “OHGR” and ISIN GB00BNNT0595.
If you have any questions about One Health Group, please contact our IR team: Walbrook PR020 7933 8780onehealth@walbrookpr.com
